Proton NMR spectra of urine from subjects with multiple acyl-CoA dehydrogenase deficiency, caused by defects in either the electron transport flavoprotein or electron transport flavoprotein ubiquinone oxidoreductase, provide a characteristic and possibly diagnostic metabolite profile. The detection of dimethylglycine and sarcosine, intermediates in the oxidative degradation of choline, should discriminate between multiple acyl-CoA dehydrogenase deficiency and related disorders Ž . involving fatty acid oxidation. The excretion rates of betaine, dimethylglycine and sarcosine in these subjects give an estimate of the minimum rates of both choline oxidation and methyl group release from betaine and reveal that the latter is comparable with the calculated total body methyl requirement in the human infant even when choline intake is very low. Our results provide a new insight into the rates of in vivo methylation in early human development. q 1998 Elsevier Science B.V. All rights reserved.
Introduction
The inherited disorder multiple acyl-CoA dehydro-Ž . genase deficiency MADD has been characterised by the accumulation of several short chain fatty acyl-CoA . ETFQO which are needed for the transfer of electrons via FAD from these acyl-CoA compounds to Ž . w x the electron transport chain ETC 4,5 . The acyl-CoA dehydrogenases affected include both those involved with fatty acid oxidation and branched-chain amino-acid catabolism.
Two neonatal onset forms of MADD have been recognised. The first is associated with severe hypoglycaemia and metabolic acidosis and congenital ab-0925-4439r98r$ 19 .00 q 1998 Elsevier Science B.V. All rights reserved.
Ž . PII S0925-4439 98 00015-5 ( ) Fig. 1 . Sites of inhibition of choline oxidation in multiple acyl-CoA dehydrogenase deficiency. Abbreviations: BADH, betaine aldehyde dehydrogenase; BHMT, betaine-homocysteine methyl transferase; CDH, choline dehydrogenase; DMGDH, dimethylglycine dehydrogenase; GNM, glycine-N-methylase; SDH, sarcosine dehydrogenase; FMHT, 5-methyltetrahydrofolate-homocysteine methyltransferase; 5-CH -H folate, 5-methyltetrahydrofolate. 3 4 normalities and presents during the first 24-48 h of life. Infants in the second category do not have congenital abnormalities, but also develop hypoglycaemia and metabolic acidosis within the first few w x days of life 5 . A third, less severely affected catew x gory, has a later, variable onset and age 5 .
Gas chromatographic and mass spectrometric Ž . GC-MS analysis of urine from affected patients has detected large increases in several short-and medium-chain dicarboxylic acids and mono-and diw x carboxylate glycine conjugates 6 . In this respect, the GC-MS urinary profile shows some similarities to that found in medium-chain acyl-CoA dehydrogenase w x deficiency 7 but differs appreciably with the additional detection of variable amounts of ethylmalonate, glutarate, isovalerylglycine, iso-and n-butyrylglycine, 2-methylbutyrylglycine and methylsuccinate.
Elevation of sarcosine in both urine and plasma w x has also been reported 2 . Two dehydrogenases which mediate reactions of choline catabolism, dimethylglycine dehydrogenase and sarcosine dehydrogenase contain covalently bound FAD and also require ETF w x and ETFQO for electron transfer to the ETC 8,9 . Conversion of betaine to dimethylglycine is potentially an important reaction in the transfer of methyl Ž . groups to form methionine Fig. 1 , the precursor of S-adenosyl methionine which is the ultimate methyl donor for creatine formation and many other important biological methylations. Choline oxidase activity w x is highest in liver and kidney 10 and betaine homocysteine methyl transferase activity is thought to be w x confined to these organs in Man 11 . However, the quantitative significance of the choline oxidation pathway in vivo is uncertain. A comparative study of hepatic choline oxidase activity indicated that the activity of the human enzyme, in adults, is very low compared to several other mammalian species being only one sixtieth that of the rat, which had the highest w x activity 12 of the species studied.
We have used proton nuclear magnetic resonance Ž 1
. H-NMR spectroscopy to characterise a number of disorders of organic acid and amino-acid metabolism, and thereby provide a means for their rapid diagnosis, by exploiting the unique ability of the technique to Ž . select C-H n containing metabolites irrespective of w x charge 13-15 . The technique is particularly applicable to the detection of intermediates in the choline oxidation pathway, e.g., betaine, dimethylglycine and Ž . sarcosine Fig. 1 . We have applied the technique to investigate the abnormal metabolites in urine from three patients who were diagnosed with MADD in order to investigate the flux through the choline Ž . oxidation pathway and simultaneously determine whether the NMR spectrum itself was diagnostic for the disorder. A preliminary report was made on a w x sample from one of these patients 16 .
Materials and methods

Patients
Patient 1 is a boy who presented at the age of 8 months with fits and hepatomegaly. At the time of Ž . sampling 2 weeks later he was still unwell, receiving glucose and saline only and therefore, negligible dietary choline. He was unresponsive to riboflavin but subsequently, he recovered rapidly and has been ( ) maintained subsequently on a normal diet with attention given to regular feeding to avoid hypoglycaemia and consequent stimulation of fatty acid and protein catabolism. He is now 8 years old and is well having developed normally. Patient 2 was a girl who presented at the age of 24 h with severe compensated metabolic acidosis after an uneventful birth. She was Ž given D,L-carnitine orally from day 2 3 = 100 mg y1 y1 . kg day , stabilised with intravenous glucose and sodium bicarbonate, then maintained on a diet with a reduced fat intake and discharged at 7 weeks. At the Ž . time of sampling 4 weeks , her condition was relatively stable. She was still receiving oral carnitine and a fat free diet containing protein and carbo-Ž hydrate. Her rate of growth was 4.5 g kg body . y1 y1 Ž weight day mean for healthy babies approx. 7 . g . The choline intake of Patient 2 was also negligible at the time of study. She was re-admitted to hospital at 4 months and died at the age of 4.5 months. Patient 3 is a girl aged 11.5 years with a mild form of the disorder and has been receiving a protein reduced diet with regular meals. None of the patients had congenital abnormalities. All diagnoses were made initially by GC-MS and confirmed when possible by the detection of CO from oxidation of fatty acids of 2 various chain lengths and leucine using cultured skin fibroblasts.
Samples
Random urine samples were analysed which had either been taken for diagnosis or therapeutic monitoring.
NMR spectroscopy
For 1 H-NMR spectroscopy urine samples were prepared as follows: 0.5 ml of urine was transferred Ž to a 5-mm outer diameter NMR tube Goss Instru-. ments, Ingatestone, Essex, UK and 50 ml of 20-mM Ž . sodium-2,2,3,3 trimethylsilyl tetradeutero-pro- . min . Ac: acetate; Ala: alanine; Bt: betaine; Cit: citrate; Cr: creatine; Crn: creatinine; Dma: dimethylamine; Dmg: dimethylglycine; Gly: glycine; Lac: lactate. For more details of assignments, see text.
( ) Ž . one dimensional 1D spectra were collected for each urine sample. Spectra were recorded either on a Jeol GSX 500 MHz or a Bruker AM600 MHz spectrometer with a 30-458 excitation pulse, an acquisition time of 1.7 s, a sweep width of 12 ppm, and a Ž . recycling time of 5 s. Solvent H O suppression was 2 performed using pre-saturation of the water resonance with a 2-s irradiation pulse of 0.2 W prior to excitation and acquisition. Some samples were then Ž re-run using a Hahn spin-echo pulse sequence 908-. t-1808-t-acquire with a pulse recycle time of 2 s and inter-pulse delay, t s 60 ms. This ensured that even-numbered and odd-numbered multiplets differed in phase by 1808.
Peak assignments were made as previously dew x scribed 13-15 . In summary, where available, authentic standards were run under the same conditions as the urine samples. Some standards were also run after varying the pH over a range which included the urine pH values. Hahn spin-echo spectra aided spectral interpretation by inverting even-numbered multiplets. In addition, a spectrum using two dimensional Ž . correlated spectroscopy COSY was recorded on the urine sample from Patient 1 to aid signal assignments by detecting through bond couplings. The 2D spectrum was recorded at 500 MHz with a sweep width of 9 ppm, an SI s 2 k, with 512 2nd dimensional time increments, an acquisition time of 0.3 s and Ž . recorded in the magnitude mode with two 908 pulses. Peak heights were used to quantify metabolites. As creatinine concentration can be determined directly from the NMR spectrum, metabolite excretion rates were expressed as a peak height ratio to creatinine. However, in infants and older children, creatine ex-Ž . cretion Fig. 2 is substantial and so, metabolite concentrations relative to the sum of creatinine plus w x creatine were also measured 17 . Fig. 2 shows a 1 H-NMR spectrum of urine from a healthy 3-month-old child. The most prominent signals are from the methyl protons of betaine, creatine and creatinine. Betaine excretion is very high in neonates and infants reaching a maximum at 2-3 months after birth, but is normally undetectable by 1 H-NMR spectroscopy in adult urine analysed under w x the same conditions 18,19 . In a group of healthy infants and children, we have found that urinary dimethylglycine is -0.10 mol mol y1 creatinine in the early neonatal period, rising to a peak of up to y1 Ž y1 0.16 mol mol at 2-3 months 0.14 mol mol in . the subject whose spectrum is shown in Fig. 2 , falling to -0.05 by 10 years, whereas sarcosine is -0.03 mol mol y1 creatinine throughout and often Ž too small to assign unambiguously Davies, Holmes, . Chalmers, Iles, unpublished .
Results
The spectrum from Patient 1 is shown in Fig. 3 . Two overlapping triplets at 0.84 and 0.88 ppm are assigned to the methyl groups of hexanoylglycine and ethylmalonate, respectively. Signals from the methyl Ž . groups of isovalerylglycine 0.94 ppm and isobu-Ž . tyrylglycine 1.12 ppm can be identified. Resonances from the methylene groups of the dicarboxylates adipate, sebacate and suberate overlap at 1.30 Ž . not adipate , 1.54-1.56 and 2.18-2.21 ppm together with methylene resonances from suberylglycine and hexanoylglycine at 1.3, 1.6 and 2.2 ppm which have an additional signal at 2.30 ppm. Neither nbutyrylglycine or 2-methylbutyrylglycine could be detected in the 1-D spectrum and the COSY spectrum did not contain the expected cross-peaks so their Ž . concentration must have been very low -50 mM . Table 1 Excretion of methyl donors and acceptors from three subjects with multiple acyl-CoA dehydrogenase deficiency measured by 1 H NMR spectroscopy Glutarate was confirmed from a characteristic cross Ž peak in the 2-D spectrum and singlets at 2.74 N-. Ž . methyl and 3.62 ppm methylene may be assigned Ž to sarcosine. Prominent resonances at 2.92 N-di-. Ž . methyl and 3.73 ppm methylene are from dimethylglycine, which is the largest component. The spec-Ž . trum from Patient 2 not shown revealed both dimethylglycine and much larger sarcosine reso-Ž . nances Table 1 but apart from glutarate signals other dicarboxylates were barely detectable. The spectrum of Patient 3 showed the presence of both sarcosine and dimethylglycine. However, only small signals were visible from adipate, sebacate and suberate and the other dicarboxylates and glycine conjugates were undetectable. Betaine aldehyde, an inter-Ž . mediate in choline conversion to betaine Fig. 1 was below NMR detection limits in all spectra. Table 1 shows the rates of excretion of metabolites associated with the choline oxidation pathway rela-Ž . tive to creatinine qcreatine excretion for the three patients. The accumulated sum of metabolites distal to the choline dehydrogenase step, i.e., the sum of betaine, dimethylglycine and sarcosine excretion is a measure of the rate of choline oxidation assuming negligible sarcosine synthesis from glycine N-meth-Ž w x . ylation Ref. 20 ; discussion below , which is probably an underestimate as the inhibition of sarcosine dehydrogenase is unlikely to be 100% especially in Patients 2 and 3 who were clinically mildly affected at the time of study. Similarly, the sum of dimethylglycine and sarcosine excretion is equivalent to the Ž . Ž . minimum rate of betaine re methylation of homocysteine.
Discussion
The 1 H-NMR urine spectra of these patients showed some superficial similarities to those from patients with medium chain acyl-CoA dehydrogenase w x deficiency 21 . This phenomenon occurs because both disorders result in the accumulation of abnormal amounts of medium-chain fatty acyl-CoA esters which are subsequently converted to dicarboxylates from v and v y 1 oxidation. However, there is a major difference in that signals from both sarcosine and especially dimethylglycine are present in the MADD spectra in addition to the short-chain fatty acyl-glycines. Increased dimethylglycine has not previously been identified in this disorder, apart from our w x preliminary study 16 , although presumably it accumulates because of the lack of ETF or ETFQO for electron transfer and consequent inhibition of dimethylglycine dehydrogenase activity. Our findings demonstrate that it may be one of the major abnormal metabolites excreted in this disorder even when the defect is relatively minor as appears to be the case in Patient 3. Thus, we conclude that the 1 H NMR spectrum may be diagnostic for this disorder.
We have shown previously that neonates excrete w x significant amounts of betaine in their urine 18,19 . It is perhaps surprising that the betainercreatinine ratio in these patients is not abnormal, lying within range of the values we have found for healthy w x neonates and infants 19 . This suggests that although dimethylglycine accumulates, betaine to dimethylglycine conversion via betaine homocysteine methyl transferase is relatively unaffected.
Because dimethylglycine arises from the transfer of a methyl group from betaine to homocysteine to form methionine, its excretion rate plus that of sarcosine gives a measurement of the rate of methylation Ž . from this reaction Fig. 1 . Methionine in the form of Ž . S-adenosyl methionine SAM is the prime methyl donor for methyl-group transfers, the majority of which are used for creatine synthesis, at least in the w x adult 20,22 . In a growing child, the rate of creatine synthesis is in effect equivalent to the rate of the sum of creatinine plus creatine excretion plus the amount of creatine incorporated into the body in muscle cells as free creatine and phosphocreatine as a result of the w x gain in muscle mass 19 . We have calculated that the increase in muscle creatine content is approximately 20% of the total synthesised in a 1-month-old child w x 19 and probably less than in Patient 2, whose growth rate was slow, and only 3% in a healthy 8-month-old child. We have previously considered also the quantitatively important requirement for methyl groups in the synthesis of phosphatidylcholine w x from phosphatidylethanolamine 19 which could, in theory, reach the equivalent of 60% of the demand for creatine synthesis. However, in the healthy individual, much of this requirement may be obviated by the synthesis of phosphatidylcholine via the CDP-Ž . choline pathway from dietary choline itself, although this is clearly not the case in Patients 1 and 2 ( ) who were receiving minimal choline in their diet at the time of study.
The other major source of methyl groups for the w x body is from dietary methionine. Krebs et al. 22 calculated that the rate of creatine synthesis, in effect Ž . equivalent to the rate of creatinine qcreatine excrew x tion 19 , is equivalent to the dietary methionine intake. We have estimated that in the neonatal period in a healthy infant, nearly all of the methyl groups provided by the methionine intake would be ac-Ž . counted for by the methionine requirement for net w protein synthesis and accumulation of muscle crea-
x Ž . tine Holmes, Snodgrass, Iles, unpublished with little or none to spare for the balance of creatine synthesis. The methylation of guanidinoacetate to form creatine is almost entirely restricted to the liver w x and pancreas 23 . Therefore, the excretion rate of w x w dimethylglycineq sarcosine relative to creatinine x q creatine is a reasonable measure of the activity of Ž . betaine homocysteine methyl transferase BHMT relative to methylation in vivo in respect of the requirement for steady state creatine synthesis. Surprisingly, the magnitude of the BHMT flux in the neonatal period suggests that this process could make Ž . a major net contribution to the total body requirement for methyl groups if the choline precursor were supplied exogenously.
Ž . The alternative reaction for re methylation of homocysteine is mediated by the enzyme 5-methyltetrahydrofolate homocysteine methyl transferase Ž . FHMT , the methyl group being provided by 5-Ž . methyltetrahydrofolate Fig. 1 . The relative contributions of the two pathways for homocysteine methylation have not yet been determined although the significance of the folate methylating system has been repeatedly emphasised, particularly as the FHMT enw x zyme is more widely distributed 24,25 . The FHMT process is presumably of particular importance in those issues that do not possess BHMT, e.g., brain. 5-Methyltetrahydrofolate is made from methylene-tetrahydrofolate. The methylene moiety can arise from serine but is also produced from the demethylation of dimethylglycine and sarcosine, reactions that are limited in MADD. Thus, our data present a paradox whereby choline oxidase activity appears to be high in the presence of low choline intake and irrespective of protein intake. In order to account for this situation, as no other precursor of betaine is known apart from betaine itself, we suggest that body endogenous stores of choline phospholipid are degraded. It is possible that a methyl group deficit is present in severe cases which might account for the demyelination observed in MRI studies of some patients with w x MADD 26 as phosphatidylcholine and sphingomyelin are degraded by phospholipases to provide choline.
The rate of methyl group release based on the estimated rate of dimethylglycine plus sarcosine ex-Ž . cretion Table 1 in the youngest subject, Patient 2, is over three times that of the methyl group requirement accounted for by creatinineq creatine excretion. That the rate of excretion of dimethylglycine and sarcosine in Patient 2 was almost twice as great as that for Patient 1 may be related to the more severe expression of the disorder in the girl and also possibly reflect the greater flux in this pathway and requirement for SAM in the neonatal and early infant period w x 27 . There is no indication that flux through the betaine demethylation pathway should be any faster in patients with MADD than in healthy children. Indeed, with virtually no choline intake, it might be expected that the flux would be decreased. Therefore, if these results can be extrapolated to apply to the normal infant, then the rate of methyl group release via the betaine homocysteine methyl transferase route would seem to be far above the total daily requirew x ment for methyl groups, in the neonatal period 18,19 . In addition, as discussed above, further metabolism of dimethylglycine via sarcosine and glycine generw x ates one-carbon fragments 28 which can, at least theoretically, also be recovered as methyl groups although incorporation into serine may be their imw x mediate fate 28 . Patient 1, at the age of 8 years, is still excreting DMG q sarcosine at approx. 0.9 mol mol y1 creatinine even though he has been asymptomatic since this episode, eating a normal diet and continuing to thrive. Some additional evidence that this extrapolation can be made to healthy subjects is provided by a 7-week-old child we have recently studied who was excreting DMG at over 1 mol y1 w x mol creatinine q creatine . He was clinically Ž . asymptomatic and had a normal formula feed diet Ž growing at the 95th percentile Holmes, Snodgrass, . Iles, unpublished . Furthermore, premature babies have a greater need for methyl groups in the early postnatal period than full-term infants yet excrete ( ) betaine at comparable rates to the latter group in spite w x of receiving very little choline in this period 29, 30 . w x Mudd et al. 20 studied sarcosine excretion in two Ž patients aged 15 and 16 with sarcosinaemia sarco-. sine dehydrogenase deficiency . Dimethylglycine was not estimated. The level of methionine and choline in the diet was varied in order to calculate what the contribution of each of these methyl donors was to the methyl supply as measured by creatinine, creatine and sarcosine excretion. At no time did the sarcosine excretion exceed the creatine and creatinine excretion. However, with excess methionine or choline intake, the sum of methionine and choline intake was greater than the creatine and creatinine excretion, but not the sum of creatine and creatinine and sarcosine. Interestingly, at all levels of choline intake, sarcosine production equalled or exceeded choline intake and Mudd et al. concluded that methionine had to be used for sarcosine synthesis. However, when methionine intake was increased, an almost equimolar increase in sarcosine excretion occurred. Given that three molecules of methionine are needed for each choline molecule synthesized, it is likely, as concluded by Mudd et al., that this sarcosine was generated by direct methylation of glycine by SAM which would seem a feasible route when methyl groups are supplied in excess. In our study, methylation of glycine is likely to be minimal since the supply of dietary methyl groups from both methionine and choline was clearly inadequate for Patient 1 and from choline insufficient for Patient 2. Patient 3 received a low Ž . protein methionine intake. Mudd et al. concluded that the rate of sarcosine formation from choline was never more than 20% of the rate of creatinine synthesis. Our results suggest that in the neonate and young infant, the rate may be higher. Even if all the urinary sarcosine was produced from glycine N-methylation, the capacity of methyl group transfer via betaine reflected in the excretion of dimethylglycine would still exceed the methylation requirement for creatine synthesis by over 60% in Patient 2 and 66% of the requirement in Patient 1.
It appears therefore, that the capacity of the human choline oxidase system in vivo may be greater than has been previously realised and that choline may play a major role in the transfer, and perhaps provision, of methyl groups and other one-carbon units in the human infant.
In conclusion, it is not clear why choline oxidation appears to be highly active in the neonatal period regardless of the dietary choline supply. These results may therefore have major consequences for choline and methionine provision in the neonatal period. Inadequate intake of one or both could lead to the degradation of endogenous phosphatidylcholine and sphingomyelin to provide choline substrate, which is clearly deleterious to development.
